Pressure Off 340B?
Two key House subcommittees will not hold hearings on the controversial 340B prescription drug discount program in the near future.
The chairs of the House Energy and Commerce Committee’s Oversight and Investigations Subcommittee and its Health Committee have both suggested that House Democrats understand the importance and value of the 340B program and see other health care issues as greater priorities.
This marks a serious departure from the last session of Congress, which saw a number of hearings on the 340B program and doubts cast about the program’s objectives and future.
Most Pennsylvania safety-net hospitals participate in the 340B program and consider it a vital resource in their efforts to serve their communities.
Learn more from the Lexology article “340B Program Gets Relief from Congressional Scrutiny.”
According to the Urban Institute report, repealing the entire Affordable Care Act would add almost 20 million Americans to the ranks of the uninsured. Medicaid and CHIP enrollment would fall by 15.4 million people and millions of others would lose the tax credits they used to purchase insurance. Some would purchase insurance with limited benefits and individual plan premiums would rise while others would go uninsured.
The
Last week the Medicaid and CHIP Payment and Access Commission released its annual report to Congress, with most of the report focusing on its analysis and recommendations for policy updates involving Medicaid disproportionate share hospital payments (Medicaid DSH) and Medicaid upper payment limit payments (UPL payments).
MACPAC commissioners discussed several statutory changes that would seek to minimize the impact of the court ruling:
According to a Pennsylvania Department of Health news release,
Included in this edition are articles about:
According to a new study published in Health Affairs,
increasing Pennsylvania’s minimum wage